JenaValve Launches Trilogy in US for Severe Aortic Regurgitation
01 Apr 2026 //
GLOBENEWSWIRE
Jenavalve Secures FDA`s 1st Approval In Aortic Regurgitation
18 Mar 2026 //
FIERCE BIOTECH
Jenavalve Appoints John Molyneux To Vice President Of Operations
29 Jan 2026 //
GLOBENEWSWIRE
FTC wins blocking Edwards Lifesciences` acquisition of JenaValve
09 Jan 2026 //
REUTERS
Edwards Comments On Jenavalve Acquisition
09 Jan 2026 //
BUSINESSWIRE
Peijia Medical Gets NMPA Approval For Taurustrio Valve System
12 Dec 2025 //
PR NEWSWIRE BIO
FTC Outlines Antitrust Case Against Edwards` Jenavalve Deal
25 Nov 2025 //
FIERCE BIOTECH
JenaValve Announces Late-Breaking ALIGN-AR Results in The Lancet
24 Nov 2025 //
GLOBENEWSWIRE
Jenavalve Marks 1,000Th Case With Trilogy Heart Valve System
17 Nov 2025 //
GLOBENEWSWIRE
JenaValve‘s Trilogy System Featured in Live Procedure at TCT 2025
10 Nov 2025 //
GLOBENEWSWIRE
ESC Guidelines Class IIb Recommend TAVI for Aortic Regurgitation
10 Sep 2025 //
GLOBENEWSWIRE
JenaValve responds to FTC action on Edwards Lifesciences deal
06 Aug 2025 //
GLOBENEWSWIRE
JenaValve Enrolls 1st Patient in AR Trial of Trilogy™
14 Jul 2025 //
GLOBENEWSWIRE
JenaValve broadcasts Trilogy™ THV System procedures at New York
07 Jul 2025 //
GLOBENEWSWIRE
JenaValve Announces Data from ALIGN-AR Trial
31 Mar 2025 //
GLOBENEWSWIRE
JenaValve Announces First Case for Inclusion in JENA-VAD Registry
16 Dec 2024 //
GLOBENEWSWIRE
JenaValve Presents 2-Year Data at TCT 2024 & ARTIST Trial Launch
12 Nov 2024 //
GLOBENEWSWIRE
JenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The Lancet
28 Mar 2024 //
GLOBENEWSWIRE
JenaValve`s Trilogy THV System Highlighted at CRT 2024
19 Mar 2024 //
GLOBENEWSWIRE
JenaValve Featured at the PCR London Valves 2023
06 Dec 2023 //
GLOBENEWSWIRE
JenaValve Announces Data from the ALIGN-AR Pivotal Trial Meeting Safety
24 Oct 2023 //
GLOBENEWSWIRE
JenaValve Announces ALIGN-AR Pivotal Data to be Presented
19 Sep 2023 //
GLOBENEWSWIRE
JenaValve Announces First Trilogy Heart Valve Systems Implanted in Asia
18 May 2023 //
GLOBENEWSWIRE
JenaValve Appoints Ken MacLeod, Ph.D. to Board of Directors
05 Apr 2023 //
GLOBENEWSWIRE
JenaValve Appoints Duane Pinto, MD, MPH, as Chief Medical Officer
24 Oct 2022 //
GLOBENEWSWIRE
JenaValve Completes Enrollment in the ALIGN-AR IDE Clinical Trial
14 Sep 2022 //
GLOBENEWSWIRE
JenaValve nabs $100M to clear a path toward FDA approval of dual-use TAVR system
31 Aug 2022 //
FIERCEBIOTECH
JenaValve Announces Results from Trilogy Heart Valve System Implants
28 Jun 2022 //
GLOBENEWSWIRE
JenaValve Appoints Kari Moore as Chief Financial Officer
17 May 2022 //
GLOBENEWSWIRE
JenaValve Announces Strategic & Licensing Agreement with Peijia Medical
18 Jan 2022 //
GLOBENEWSWIRE
JenaValve Receives IDE Approval to Initiate The ALIGN-AR Pivotal PMA Trial
16 Aug 2021 //
GLOBENEWSWIRE

Market Place
Sourcing Support